News

Mylan N.V. announced an agreement to acquire the related intellectual property and commercialization rights of Aspen Pharmacare Holdings Limited's thrombosis business in Europe for EUR…
Read More...

Immune Regulation Ltd, a US and UK based clinical stage biotechnology company, announced that it has received a notice of allowance from the U.S. Patent and Trademark Office (USPTO) for…
Read More...

AnHeart Therapeutics, Co., Ltd. a clinical stage oncology company focused on underserved patients in global markets, has through its subsidiary AnHeart Therapeutics Inc. entered into…
Read More...

Grifols announced it has entered into a transaction to acquire the remaining equity of Alkahest, Inc. in exchange for a total price of $146 million, on a debt-free basis. No additional…
Read More...

Destiny Pharma plc, a clinical stage biotechnology company focused on the development of novel, hospital infection prevention treatments that address the global challenge of…
Read More...

IcanoMAB, a privately-funded biotech company focusing on the pre-clinical and clinical development of novel precision canonical antibodies for the treatment of cancer, immune-system…
Read More...

Kite, a Gilead Company announced that it has submitted a supplemental Biologics License Application (sBLA) to the U.S. Food and Drug Administration (FDA) for Yescarta (axicabtagene…
Read More...

AbbVie and I-Mab announced that AbbVie and I-Mab have signed a broad, global collaboration agreement for the development and commercialization of lemzoparlimab (also known as TJC4), an…
Read More...

Ehave, Inc. a provider of digital therapeutics delivering evidence-based therapeutic interventions to patients, announced it is entering into a licensing agreement with a telemedicine…
Read More...

PPD, Inc. and Lupus Therapeutics (LT), an affiliate of the Lupus Research Alliance known for its lupus clinical trials expertise, have entered into a collaboration to expand and enhance…
Read More...

On 2 September, WHO published guidance for clinicians and health care decision-makers on the use of corticosteroids in patients with COVID-19. We recommend systemic corticosteroids…
Read More...

Sanofi and GSK announce the start of the Phase 1/2 clinical trial for their adjuvanted COVID-19 vaccine. The vaccine candidate, developed in partnership by Sanofi and GSK, uses the same…
Read More...

Kite, a Gilead Company, and HiFiBiO Therapeutics announced the companies have entered into a two-year research collaboration and license agreement in acute myeloid leukemia (AML).…
Read More...

Enesi Pharma, an innovative biotechnology company developing next-generation vaccination products targeting serious diseases, is delighted to announce its partnership with the…
Read More...

The U.S. Food and Drug Administration (FDA) approved two additional doses of Eli Lilly and Company's Trulicity (dulaglutide). The approval expands the label of once-weekly Trulicity to…
Read More...

Santhera Pharmaceuticals announces that it has signed agreements with Idorsia and ReveraGen BioPharma Inc., making Santhera a direct license holder of vamorolone. Under the agreements,…
Read More...

BiomX Inc. a clinical stage company developing natural and engineered phage therapies that target specific pathogenic bacteria, announced that it has entered into a collaboration with…
Read More...

Selexis SA and Igyxos announced that they have entered into a service agreement to develop Igyxos’ first-in-class monoclonal antibody (mAb) drug candidate for the treatment of human…
Read More...

Oxford Biomedica plc announced that it has signed an 18 month supply agreement under a three year Master Supply and Development Agreement with AstraZeneca UK Ltd for large-scale…
Read More...

Gilead Sciences, Inc. announced an agreement with Jounce Therapeutics, Inc. a clinical-stage company focused on the discovery and development of novel cancer immunotherapies and…
Read More...